Login
Navigate Fool.com
Will GSK beat
the market?

GlaxoSmithKline

NYSE: GSK

Community Rating: 4 Stars: Favorite

51.48 -0.99 (-1.89%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $52.33
Previous Close $52.47
Daily Range $51.46 - $52.49
52-Week Range $41.68 - $54.00
Market Cap $126.6B
P/E Ratio 15.80
Dividend (Yield) $2.20 (4.5%)
Ex-Dividend Date
Dividend Pay Date
05/08/13
07/11/13
Volume 1,902,124
Average Daily Volume 2,616,132
Current FY EPS $3.60

How do you think GSK
will perform against the market?

Top GSK Bull/Bear Pitches

 

There are no pitches that meet the Top Bull criteria. Explain

If this upsets you, start recommending pitches here!

 

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches here!

News & Commentary

The Top 3 Medical Uses of Botox

Despite being well-known for curing wrinkles, Botox has important therapeutic uses, too.

Pharma Rx? $105B Saved If Patients Took Meds

3 Views for Sarepta on Prosensa's IPO

What does the planned Prosensa IPO mean for Sarepta? Here are 3 views.

Why MannKind Is Poised to Pull Back

Market-lagging returns could be written in this 2-star stock.

Glaxo Gets Offer For Thrombosis Brands, Related Manufacturing Site

GlaxoSmithKline PLC GSK receives offer for Thrombosis Brands

Does Restless Legs Syndrome Really Shorten Life Span?

A new study suggests a link between this neurological disorder and mortality rates in men.

Pharma Stocks: Court Ruling's Real Meaning

Studies Fail to Back Medtronic Spine Product

Merck HPV Vaccine Sales Surge Despite Concerns

See More GSK News...

Sector

Healthcare

Industry

Drugs

GlaxoSmithKline (GSK) Description

The Company is a global healthcare group which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter medicines and health-related consumer products. Website: http://www.gsk.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks